Search - tctmd.com

Displaying 261 - 280 of 1510

Sort: Relevancy | Date

Presentation TVT 2022

Redefining the Future of Aortic Stenosis: Diagnosis, Classification, and Management

Presenter: Martin Leon

June 08, 2022

Presentation TVT 2022

Moderate AS With Evidence of Cardiac Damage: The PROGRESS Trial

Presenter: Philippe Genereux

June 08, 2022

Presentation TVT 2022

Moderate AS With Heart Failure: Updates and Lessons From TAVR UNLOAD

Presenter: Nicolas Van Mieghem

June 08, 2022

Presentation TVT 2022

Severe AS With No Symptoms: Updates From Surgical Trials, EARLY TAVR, and EVOLVE

Presenter: Mark Russo

June 08, 2022

Presentation TVT 2022

Peri-Procedure segment; minimizing TAVR staff, TAVR step down unit

Presenter: Andrei Pop

June 08, 2022

Presentation TVT 2022

Pre-Procedure segment; efficiently working-up your TAVR patient

Presenter: Joseph Walsh

June 08, 2022

Presentation TVT 2022

Aortic Stenosis and lack of treatment during/post COVID-19, staffing issues and efficiency programs for TAVR optimization

Presenter: Vijay Iyer

June 08, 2022

Presentation TVT 2022

Transcatheter Aortic Valve Replacement With the Self-Expanding ACURATE neo2: Hemodynamic Performance and Clinical Outcomes

Presenter: Andrea Scotti

June 08, 2022

Presentation TVT 2022

Evidence of Structural Valve Deterioration After TAVI: Recent Echo Findings

Presenter: Michael J. Reardon

June 08, 2022

Presentation TVT 2022

Surgical Explants After TAVI Failures: Prohibitive or an Acquired Taste

Presenter: Tsuyoshi Kaneko

June 08, 2022

Presentation TVT 2022

Technical Lessons From TAVI Valve-in-Valve: Contrasting TAV in SAVR and TAV in TAV

Presenter: Janarthanan Sathananthan

June 08, 2022

Presentation TVT 2022

COUNTERPOINT: EU Preferences… Class 1 = ≥ 75 yo

Presenter: Haim Danenberg

June 08, 2022

Presentation TVT 2022

POINT: U.S. Reflections… Class 1 = ≥ 65 yo

Presenter: Philippe Genereux

June 08, 2022

Presentation TVT 2022

EFFICACY AND SAFETY OUTCOMES OF CEREBRAL EMBOLIC PROTECTION DEVICES DURING TRANSCATHETER AORTIC VALVE REPLACEMENT: AN UPDATED META-ANALYSIS

Presenter: Arpanjeet Kaur

June 08, 2022

Presentation TVT 2022

Pattern of Hospital-Level Use of Cerebral Embolic Protection for Transcatheter Aortic Valve Replacement and Association with Outcomes

Presenter: AAMER UBAID

June 08, 2022

Presentation TVT 2022

Transcatheter versus surgical aortic valve replacement for severe aortic stenosis: a meta-analysis of randomized clinical trials

Presenter: Yousif Ahmad

June 08, 2022

Presentation TVT 2022

Health-Related Quality of Life after TAVR According to Baseline Flow State and Aortic Valve Gradients

Presenter: Ibrahim Khaleel

June 08, 2022

Presentation TVT 2022

Alternative Transcatheter Solutions

Presenter: Lauren Ranard

June 08, 2022

Presentation TVT 2022

Frequency, Mechanisms, and Current Management

Presenter: Nir Uriel

June 08, 2022

Presentation TVT 2022

Rapidly Evolving EU Experiences With the JenaValve for AR and AS

Presenter: Matti Adam

June 08, 2022

Advertisement

Redefining the Future of Aortic Stenosis: Diagnosis, Classification, and Management

Moderate AS With Evidence of Cardiac Damage: The PROGRESS Trial

Moderate AS With Heart Failure: Updates and Lessons From TAVR UNLOAD

Severe AS With No Symptoms: Updates From Surgical Trials, EARLY TAVR, and EVOLVE

Peri-Procedure segment; minimizing TAVR staff, TAVR step down unit

Pre-Procedure segment; efficiently working-up your TAVR patient

Aortic Stenosis and lack of treatment during/post COVID-19, staffing issues and efficiency programs for TAVR optimization

Transcatheter Aortic Valve Replacement With the Self-Expanding ACURATE neo2: Hemodynamic Performance and Clinical Outcomes

Evidence of Structural Valve Deterioration After TAVI: Recent Echo Findings

Surgical Explants After TAVI Failures: Prohibitive or an Acquired Taste

Technical Lessons From TAVI Valve-in-Valve: Contrasting TAV in SAVR and TAV in TAV

COUNTERPOINT: EU Preferences… Class 1 = ≥ 75 yo

POINT: U.S. Reflections… Class 1 = ≥ 65 yo

EFFICACY AND SAFETY OUTCOMES OF CEREBRAL EMBOLIC PROTECTION DEVICES DURING TRANSCATHETER AORTIC VALVE REPLACEMENT: AN UPDATED META-ANALYSIS

Pattern of Hospital-Level Use of Cerebral Embolic Protection for Transcatheter Aortic Valve Replacement and Association with Outcomes

Transcatheter versus surgical aortic valve replacement for severe aortic stenosis: a meta-analysis of randomized clinical trials

Health-Related Quality of Life after TAVR According to Baseline Flow State and Aortic Valve Gradients

Alternative Transcatheter Solutions

Frequency, Mechanisms, and Current Management

Rapidly Evolving EU Experiences With the JenaValve for AR and AS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content